Tokyo Tape
Sign in
← Jmdc

Quarterly report · Q1

4483.TEDINET S100P0TK
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥5.8bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥21.8bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥4.5bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥823m2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥4.8bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥806m2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥765m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥538m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥759m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥538m2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥63.3bnat 2022-06-30Cons.Assets IFRS
Total assets¥62.1bnat 2022-03-31Cons.Assets IFRS
Total assets¥57.3bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥31.9bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥30.9bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥31.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥31.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥31.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥31.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥28.3bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥10.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥17.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥19.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥3.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥805m2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥8.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥909m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.4bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥13.552022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥57.742021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥9.622021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥12.732022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥54.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥9.032021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio49.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥90m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥910m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥869m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥41m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥47m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2022-04-01 → 2022-06-30¥1.1bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥439m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥58m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥74m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥782m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥755m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥27m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥49m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2021-04-01 → 2021-06-30¥2.8bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2021-04-01 → 2021-06-30¥2.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥8m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2021-04-01 → 2021-06-30¥858m
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥330m
—segment totalrevenue2021-04-01 → 2021-06-30¥4.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥4.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥35m
—segment totalsegment profit2021-04-01 → 2021-06-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 683
ItemContextValueUnit
Comprehensive income IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember4000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Issuance of share acquisition rights ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Share based payment transactions ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember21000000JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember21000000JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Exercise of share acquisition rights ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember-0JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Purchase of treasury shares ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Dividends ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Increase decrease by business combination ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4000000JPY
Transfer to retained earnings ss IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareCapitalIFRSMember21000000JPY
Total transactions with owners IFRSCurrentYTDDuration_CapitalSurplusIFRSMember21000000JPY
Total transactions with owners IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-4000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember-0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass